Les Sulewski
Stock Analyst at Truist Financial
(3.92)
# 1,974
Out of 4,662 analysts
185
Total ratings
50%
Success rate
8.6%
Average return
Main Sectors:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRMD CorMedix | Maintained: Buy | n/a | $8.52 | - | 23 | May 15, 2026 | |
| COLL Collegium Pharmaceutical | Maintained: Buy | n/a | $28.74 | - | 20 | May 14, 2026 | |
| ANIP ANI Pharmaceuticals | Maintained: Hold | n/a | $78.02 | - | 25 | May 11, 2026 | |
| VTRS Viatris | Reiterated: Buy | $20 | $16.25 | +23.11% | 8 | May 8, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintained: Buy | $18 | $5.57 | +223.16% | 4 | May 7, 2026 | |
| PCRX Pacira BioSciences | Maintained: Buy | n/a | $24.36 | - | 24 | May 1, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Reiterated: Hold | n/a | $9.48 | - | 18 | May 1, 2026 | |
| TEVA Teva Pharmaceutical Industries | Rated: Buy | $42 → $45 | $37.47 | +20.10% | 11 | Apr 30, 2026 | |
| AMRX Amneal Pharmaceuticals | Maintained: Buy | n/a | $18.11 | - | 21 | Apr 23, 2026 | |
| BTMD biote | Maintained: Buy | $5 → $4 | $1.36 | +194.12% | 19 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | €22.00 | €24.88 | n/a | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $93.65 | n/a | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23.63 → $19.46 | $17.95 | n/a | 5 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.21 | n/a | 5 | Jul 9, 2024 |
CorMedix
May 15, 2026
Maintained: Buy
Price Target: n/a
Current: $8.52
Upside: -
Collegium Pharmaceutical
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $28.74
Upside: -
ANI Pharmaceuticals
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $78.02
Upside: -
Viatris
May 8, 2026
Reiterated: Buy
Price Target: $20
Current: $16.25
Upside: +23.11%
Vanda Pharmaceuticals
May 7, 2026
Maintained: Buy
Price Target: $18
Current: $5.57
Upside: +223.16%
Pacira BioSciences
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $24.36
Upside: -
Bausch Health Companies Inc.
May 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $9.48
Upside: -
Teva Pharmaceutical Industries
Apr 30, 2026
Rated: Buy
Price Target: $42 → $45
Current: $37.47
Upside: +20.10%
Amneal Pharmaceuticals
Apr 23, 2026
Maintained: Buy
Price Target: n/a
Current: $18.11
Upside: -
biote
Apr 16, 2026
Maintained: Buy
Price Target: $5 → $4
Current: $1.36
Upside: +194.12%
May 27, 2025
Initiated Coverage: Buy
Price Target: €22.00
Current: €24.88
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $93.65
Upside: n/a
Jul 26, 2024
Maintained: Buy
Price Target: $23.63 → $19.46
Current: $17.95
Upside: n/a
Jul 9, 2024
Rated: Hold
Price Target: n/a
Current: $5.21
Upside: n/a